PMID: 6384796Jul 1, 1984Paper

Effects of exogenous prostaglandins on the release of leukotriene C4-like immunoreactivity and on coronary flow in indomethacin-treated anaphylactic guinea-pig hearts

Naunyn-Schmiedeberg's Archives of Pharmacology
U AehringhausB A Peskar

Abstract

It is known that both vasoconstrictor cyclooxygenase products and sulfidopeptide-containing leukotrienes (LT) contribute to the biphasic coronary constriction observed in isolated perfused anaphylactic guinea-pig hearts. We have now investigated the effects of the cyclooxygenase inhibitor indomethacin and of several exogenous prostaglandins (PG) on the release of LTC4-like immunoreactivity and on various symptoms of cardiac anaphylaxis. Indomethacin decreased basal coronary flow and delayed the onset of coronary vasoconstriction after antigenic challenge. Furthermore, indomethacin inhibited cardiac release of 6-keto-PGF1 alpha and thromboxane (TX) B2 and simultaneously enhanced the antigen-induced release of LTC4-like immunoreactivity significantly. Neither the vasodilators PGE2 and PGI2 nor the vasoconstrictors PGF2 alpha, PGD2 and 11,9-epoxymethano-PGH2, a compound with biological properties similar to TXA2, affected the anaphylactic release of immunoreactive LTC4 in the presence of indomethacin. These results suggest that the indomethacin-induced increase in LT release is not due to inhibition of synthesis of a cyclooxygenase product, which normally curbs anaphylactic release of immunoreactive LTC4. The indomethacin effect m...Continue Reading

References

Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·R C MurphyB Samuelsson
Jun 1, 1976·Life Sciences·R LeviJ H Zavecz
Jul 1, 1977·European Journal of Pharmacology·H AnhutB A Peskar
Aug 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·M HambergB Samuelsson
May 1, 1971·Proceedings of the Society for Experimental Biology and Medicine·W J KoopmanK F Austen
Aug 1, 1983·Prostaglandins, Leukotrienes, and Medicine·W SziegoleitW Förster
Sep 1, 1983·British Journal of Pharmacology·U AehringhausR H Wölbling
May 1, 1982·British Journal of Pharmacology·L G Letts, P J Piper
Dec 1, 1952·The Journal of Physiology·J L MONGAR, H O Schild
Mar 18, 1960·Acta Physiologica Scandinavica·N CHAKRAVARTY

Citations

Feb 1, 1986·Prostaglandins·B A PeskarB M Peskar
Mar 1, 1997·Journal of Lipid Mediators and Cell Signalling·G FeuersteinS Vonhof
Jan 1, 1988·Annals of the New York Academy of Sciences·G MaroneC Vigorito
Mar 1, 1987·British Journal of Pharmacology·S A Galton, P J Piper
Oct 4, 2000·Physiological Reviews·G MontrucchioG Camussi

Related Concepts

Related Feeds

Anaphylaxis

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.